Sponsor or institution
Clinical trials and research at Johann Wolfgang Goethe University Hospital
As of November 12, 2026, Find a Trial lists 2 clinical trials run by Johann Wolfgang Goethe University Hospital that are recruiting, in Germany. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 1Country
All recruiting trials (2)
-
Improving cardiovascular risk stratification with T1 mapping in the general population
This project will test whether CMR T1/T2 mapping can detect early heart inflammation or fibrosis and help predict cardiovascular risk in adults without known heart disease, including people after COVID-19 infection or vaccination.
-
Intracranial NK-92 cell injections plus IV ezabenlimab for recurrent HER2‑positive glioblastoma
This trial will test whether injecting engineered NK-92 immune cells into the brain together with intravenous ezabenlimab is safe and shows signs of benefit in adults with recurrent HER2‑positive glioblastoma.
Quick answers
How many clinical trials run by Johann Wolfgang Goethe University Hospital are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
All of them have sites in Germany. Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.